James L. Kepner

7.1k total citations · 1 hit paper
76 papers, 5.0k citations indexed

About

James L. Kepner is a scholar working on Statistics and Probability, Genetics and Neurology. According to data from OpenAlex, James L. Kepner has authored 76 papers receiving a total of 5.0k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Statistics and Probability, 17 papers in Genetics and 16 papers in Neurology. Recurrent topics in James L. Kepner's work include Glioma Diagnosis and Treatment (17 papers), Statistical Methods in Clinical Trials (16 papers) and Optimal Experimental Design Methods (14 papers). James L. Kepner is often cited by papers focused on Glioma Diagnosis and Treatment (17 papers), Statistical Methods in Clinical Trials (16 papers) and Optimal Experimental Design Methods (14 papers). James L. Kepner collaborates with scholars based in United States, Canada and Switzerland. James L. Kepner's co-authors include Henry S. Friedman, Larry E. Kun, Peter C. Burger, Kunle Odunsi, Brian N. Bundy, Christine B. Ambrosone, Achim A. Jungbluth, Haruo Ohtani, Hiroyoshi Nishikawa and Sara H. Olson and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Journal of the American Statistical Association.

In The Last Decade

James L. Kepner

73 papers receiving 4.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Intraepithelial CD8⁺tumor-infiltrating lymphocytes and a high CD8⁺/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer

2005 1.9k citations James L. Kepner et al. profile →

Peers

James L. Kepner

ONCOL

IMMUN

GENET

NEURO

Charlotte M. Niemeyer Germany

Jan Cools Belgium

Michael Møller Denmark

Antonio Pinto Italy

Ulrich Jaeger Austria

Giancarlo Vecchio Italy

Karen Leroy France

George W. Wright United States

Joan M. O’Brien United States

Elaine Coustan‐Smith United States

Charlotte M. Niemeyer Germany

James L. Kepner

1.6k ×0.9

ONCOL

2.1k ×1.4

IMMUN

4.1k ×2.8

1.8k ×1.2

GENET

497 ×0.6

NEURO

Citations per year, relative to James L. Kepner James L. Kepner (= 1×) peers Charlotte M. Niemeyer

Countries citing papers authored by James L. Kepner

Since Specialization

Citations

This map shows the geographic impact of James L. Kepner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James L. Kepner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James L. Kepner more than expected).

Fields of papers citing papers by James L. Kepner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James L. Kepner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James L. Kepner. The network helps show where James L. Kepner may publish in the future.

Co-authorship network of co-authors of James L. Kepner

This figure shows the co-authorship network connecting the top 25 collaborators of James L. Kepner. A scholar is included among the top collaborators of James L. Kepner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James L. Kepner. James L. Kepner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bernstein, Zale P., Thomas J. Dougherty, Sandra O. Gollnick, et al.. (2008). Photopheresis in HIV-1 Infected Patients Utilizing Benzoporphyrin Derivative (BPD) Verteporfin and Light. Current HIV Research. 6(2). 152–163. 7 indexed citations

Iyer, Renuka, John F. Gibbs, Boris W. Kuvshinoff, et al.. (2007). A Phase II Study of Gemcitabine and Capecitabine in Advanced Cholangiocarcinoma and Carcinoma of the Gallbladder: A Single-Institution Prospective Study. Annals of Surgical Oncology. 14(11). 3202–3209. 56 indexed citations

Korones, David N., Paul G. Fisher, Cynthia S. Kretschmar, et al.. (2007). Treatment of children with diffuse intrinsic brain stem glioma with radiotherapy, vincristine and oral VP‐16: A Children's Oncology Group phase II study. Pediatric Blood & Cancer. 50(2). 227–230. 83 indexed citations

Fakih, Marwan, Candace S. Johnson, Josephia R. Muindi, et al.. (2005). A phase I and pharmacokinetic (PK) study of intravenous (IV) calcitriol and gefitinib assessing EGFR pharmacodynamic (PD) interactions through serial skin biopsies. Cancer Research. 65. 941–941. 1 indexed citations

Chintagumpala, Murali, Henry S. Friedman, Clinton F. Stewart, et al.. (2005). A phase II window trial of procarbazine and topotecan in children with high-grade glioma: a report from the children’s oncology group. Journal of Neuro-Oncology. 77(2). 193–198. 16 indexed citations

Mortazavi, Amir, Aasma Shaukat, James L. Kepner, et al.. (2005). Postoperative Computed Tomography Scan Surveillance for Patients With Stage II and III Colorectal Cancer. American Journal of Clinical Oncology. 28(1). 30–35. 10 indexed citations

Shaukat, Aasma, Amir Mortazavi, Todd L. Demmy, et al.. (2004). Should preoperative, post-chemoradiotherapy endoscopy be routine for esophageal cancer patients?. Diseases of the Esophagus. 17(2). 129–135. 11 indexed citations

Kepner, James L. & Myron Chang. (2004). Samples of exact k-stage group sequential designs for Phase II and Pilot studies. Controlled Clinical Trials. 25(3). 326–333. 13 indexed citations

Hinrichs, Christian S., John F. Gibbs, Deborah Driscoll, et al.. (2004). The effectiveness of complete decongestive physiotherapy for the treatment of lymphedema following groin dissection for melanoma. Journal of Surgical Oncology. 85(4). 187–192. 29 indexed citations

10.

Dreyer, ZoAnn E., Richard Kadota, Clinton F. Stewart, et al.. (2003). Phase 2 study of idarubicin in pediatric brain tumors: Pediatric OncologyGroup study POG 9237. Neuro-Oncology. 5(4). 261–267. 23 indexed citations

11.

Hurwitz, Craig A., Lewis C. Strauss, James L. Kepner, et al.. (2001). Paclitaxel for the Treatment of Progressive or Recurrent Childhood Brain Tumors: A Pediatric Oncology Phase II Study. The American journal of pediatric hematology/oncology. 23(5). 277–281. 45 indexed citations

12.

Mahoney, Donald H., Michael E. Cohen, Henry S. Friedman, et al.. (2000). Carboplatin is effective therapy for young children with progressiveoptic pathway tumors: A Pediatric Oncology Group phase II study. Neuro-Oncology. 2(4). 213–220. 79 indexed citations

13.

Hutchison, R., James L. Kepner, Christine Fuller, et al.. (2000). Burkitt lymphoma is immunophenotypically different from Burkitt-like lymphoma in young persons. Annals of Oncology. 11. S35–S38. 19 indexed citations

14.

Chang, Myron, Jonathan J. Shuster, & James L. Kepner. (1999). Group Sequential Designs for Phase II Trials With Historical Controls. Controlled Clinical Trials. 20(4). 353–364. 11 indexed citations

15.

Reardon, David A., Jack Sublett, Susan T. Ragsdale, et al.. (1999). Chromosome arm 6q loss is the most common recurrent autosomal alteration detected in primary pediatric ependymoma. Genes Chromosomes and Cancer. 24(3). 230–237. 73 indexed citations

16.

Tihan, Tarık, Paul G. Fisher, James L. Kepner, et al.. (1999). Pediatric Astrocytomas with Monomorphous Pilomyxoid Features and a Less Favorable Outcome. Journal of Neuropathology & Experimental Neurology. 58(10). 1061–1068. 210 indexed citations

17.

Burger, Peter C., Tarık Tihan, Henry S. Friedman, et al.. (1998). Atypical Teratoid/Rhabdoid Tumor of the Central Nervous System: A Highly Malignant Tumor of Infancy and Childhood Frequently Mistaken for Medulloblastoma. The American Journal of Surgical Pathology. 22(9). 1083–1092. 315 indexed citations

18.

Kepner, James L. & Dennis D. Wackerly. (1996). On Rank Transformation Techniques for Balanced Incomplete Repeated-Measures Designs. Journal of the American Statistical Association. 91(436). 1619–1625. 8 indexed citations

19.

Ernst, Michael D. & James L. Kepner. (1993). A monte carlo study of rank tests for repeated measures designs. Communications in Statistics - Simulation and Computation. 22(3). 671–678. 5 indexed citations

20.

Kepner, James L. & David Robinson. (1988). Nonparametric Methods for Detecting Treatment Effects in Repeated-Measures Designs. Journal of the American Statistical Association. 83(402). 456–461. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact